AMED

Amedisys

Delisted

AMED was delisted on the 14th of August, 2025.

387 hedge funds and large institutions have $7.52B invested in Amedisys in 2021 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 136 increasing their positions, 151 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less funds holding

Funds holding:

less first-time investments, than exits

New positions opened: | Existing positions closed:

12% less capital invested

Capital invested by funds: $8.52B → $7.52B (-$996M)

15% less call options, than puts

Call options by funds: $33.9M | Put options by funds: $40M

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
387
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$33.9M
Puts
$40M
Net Calls
Net Calls Change

Top Buyers

1 +$93.9M
2 +$69.7M
3 +$61.5M
4
RP
Riverbridge Partners
Minnesota
+$47.3M
5
BlackRock
BlackRock
New York
+$32M
Name Holding Trade Value Shares
Change
Change in
Stake
301
$246K
302
$245K
303
$237K
304
$229K
305
$229K
306
$226K
307
$223K
308
$221K
309
$220K
310
$212K
311
$202K
312
$185K
313
$172K
314
$167K
315
$164K
316
$159K
317
$159K
318
$157K
319
$145K
320
$122K
321
$120K
322
$119K
323
$119K
324
$115K
325
$80K